Cabiles, Jesus G.

HRN: 28-60-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
AZITHROMYCIN 500MG TABLET (TAB)
02/23/2026
02/28/2026
PO
500mg
OD
CAP
Remove - Pending Acceptance
03/02/2026
CEFTRIAXONE 1G (VIAL)
03/02/2026
03/09/2026
IV
2g
OD
PTB
Checking Initial Appropriateness 
03/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/05/2026
03/12/2026
IV
4.5g
Q8
CAP HR
Checking Initial Appropriateness 
03/10/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/10/2026
03/17/2026
IV
500mg
OD
Infection
Checking Initial Appropriateness 
03/12/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/12/2026
03/18/2026
IV
1,200mg
OD
Pneumonia
Checking Initial Appropriateness 
03/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/12/2026
03/18/2026
IV
750mg
OD
Pneumonia
Checking Initial Appropriateness 
03/23/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2026
03/30/2026
IV
1200 Mg
OD
Ventilator Associated Pneumonia
Checking Initial Appropriateness 
04/02/2026
COTRIMOXAZOLE 960MG (TAB)
04/02/2026
04/09/2026
ORAL
160/800mg
2 Tabs Now, Then Q 12
VAP
Remove - Pending Acceptance
04/02/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/02/2026
04/09/2026
IV
750mg
OD
VAP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: